<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05044767</url>
  </required_header>
  <id_info>
    <org_study_id>PEPS</org_study_id>
    <nct_id>NCT05044767</nct_id>
  </id_info>
  <brief_title>Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty</brief_title>
  <official_title>Observational and Prospective Multicenter Study to Evaluate the Long-term (10 Years) Performance and Safety (10 Years) of ATF Implants and Lapé Médical Devices Implanted During Total Hip Arthroplasty or Hemiarthroplasty.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ATF Implants</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ATF Implants</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational and prospective multicenter study to evaluate the long-term (10 years)&#xD;
      performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during&#xD;
      total hip arthroplasty or hemiarthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational and prospective multicenter study to evaluate the long-term (10 years)&#xD;
      performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during&#xD;
      total hip arthroplasty or hemiarthroplasty.&#xD;
&#xD;
      The post-market clinical follow-up study to be conducted by ATF Implants following this plan&#xD;
      aims to collect data from the follow-up of patients before and after hip replacement surgery&#xD;
      with implants manufactured by ATF Implants and Lapé médical. In current practice, the&#xD;
      surgeon-investigator evaluates the patient pre- and post-operatively according to predefined&#xD;
      criteria used in orthopedic surgery and more particularly in hp replacement surgery.&#xD;
      Complications and adverse effects observed are also recorded.&#xD;
&#xD;
      The main objective is to gather clinical evidence to evaluate the survival rate of ATP&#xD;
      Implants and Lapé médical hip prostheses over the long-term, namely 10 years.&#xD;
&#xD;
      The secondary objectives are to evaluate the performance and safety of the prostheses over&#xD;
      the same period (i.e. 10 years), as well as to obtain feedback on the performance /intended&#xD;
      use and safety of the surgical instruments required for implant placement.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 7, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2032</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2032</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Long-term survival rate</measure>
    <time_frame>10 years</time_frame>
    <description>Long-term survival rate of the prostheses (10 years) with failure defined as revision surgery when considering all causes using Kaplan-Meier method.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hip joint function</measure>
    <time_frame>before and after surgery (6 month, 2 years, 5 years, 7 years, 10 years)</time_frame>
    <description>The evolution of hip joint function, and in this case the degree of physical disability before and after an intervention with Merle d'Aubigné score (PMA score) or Harris Hip Score (HHS score) or Parker score</description>
  </secondary_outcome>
  <enrollment type="Anticipated">4500</enrollment>
  <condition>Arthroplasty, Hip, Replacement</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>total hip arthroplasty</intervention_name>
    <description>hip replacement surgery</description>
    <other_name>hemiarthroplasty</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Male or female indicated for hip replacement surgery with hip prosthesis manufactured by&#xD;
        ATF Implants and/or Lapé médical.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female indicated for hip replacement surgery with hip prosthesis manufactured&#xD;
             by ATF Implants and/or Lapé médical;&#xD;
&#xD;
        There are different indications for hip replacement surgery. The main ones are listed&#xD;
        below:&#xD;
&#xD;
          -  Dysplasia&#xD;
&#xD;
          -  Primary Coxarthrosis&#xD;
&#xD;
          -  Secondary Coxarthrosis&#xD;
&#xD;
          -  Perthes disease&#xD;
&#xD;
          -  Epiphysiolysis&#xD;
&#xD;
          -  Ankylosing spondylitis&#xD;
&#xD;
          -  Trochanteric bursitis&#xD;
&#xD;
          -  Arthritis&#xD;
&#xD;
          -  Degenerative arthritis&#xD;
&#xD;
          -  Post-traumatic arthritis&#xD;
&#xD;
          -  Rheumatoid arthritis&#xD;
&#xD;
          -  Femoral neck fracture&#xD;
&#xD;
          -  Osteonecrosis&#xD;
&#xD;
          -  Revision&#xD;
&#xD;
        Depending on the specificities of the devices (size, absence/presence of a coating,&#xD;
        material), indications may vary. This information can be found in the instruction for use.&#xD;
        It is the surgeon's responsibility to select the most appropriate prosthesis for a given&#xD;
        patient according to the patient's medical records and the instruction for use in force at&#xD;
        the time of the procedure accompanying the medical device.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are various contraindications for hip arthroplasty. The main ones are listed&#xD;
             below:&#xD;
&#xD;
               -  An acute or chronic, local or systemic infection&#xD;
&#xD;
               -  Severe muscular, neurological or vascular deficiency compromising the affected&#xD;
                  extremity&#xD;
&#xD;
               -  A bone defect or insufficient bone quality that may compromise the stability of&#xD;
                  the implant&#xD;
&#xD;
               -  Any concomitant disease (dysplastic coxarthrosis with extreme coxa valga, short&#xD;
                  neck and severe varus) that may affect the function of the implant&#xD;
&#xD;
               -  Sensitivity to the material (allergy) Depending on the specificities of the&#xD;
                  devices (size, absence/presence of a coating, material), contraindications may&#xD;
                  vary. This information can be found in the instruction for use of the devices.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Laffargue, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinique du Croisé Laroche</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Philippe Laffargue, Pr</last_name>
    <phone>891650494</phone>
    <phone_ext>+33</phone_ext>
    <email>plaffargue@yahoo.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Bordeaux - Hôpital Pellegrin</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent Souillac</last_name>
      <phone>556795544</phone>
      <phone_ext>+33</phone_ext>
      <email>vincent.souillac@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Souillac, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique des Cèdres</name>
      <address>
        <city>Cornebarrieu</city>
        <zip>31700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan Hourtal</last_name>
      <phone>562133131</phone>
      <phone_ext>+33</phone_ext>
      <email>jonathanhourtal@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jonathan Hourtal, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé Drôme Ardèche</name>
      <address>
        <city>Guilherand-Granges</city>
        <zip>07500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Richard Philippe</last_name>
      <phone>475823180</phone>
      <phone_ext>+33</phone_ext>
      <email>rphilippe@orange.fr</email>
    </contact>
    <investigator>
      <last_name>Richard Philippe, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Bordeaux Rive Droite</name>
      <address>
        <city>Lormont</city>
        <zip>33310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Vincent Langlois</last_name>
      <phone>524573632</phone>
      <phone_ext>+33</phone_ext>
      <email>vincentlanglois@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Vincent Langlois, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique du Croisé Laroche</name>
      <address>
        <city>Marcq-en-Barœul</city>
        <zip>59700</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe Laffargue</last_name>
      <phone>891650494</phone>
      <phone_ext>+33</phone_ext>
      <email>plaffargue@yahoo.fr</email>
    </contact>
    <investigator>
      <last_name>Philippe Laffargue, Prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Saint George</name>
      <address>
        <city>Nice</city>
        <zip>06100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hervé Ovadia</last_name>
      <phone>493817150</phone>
      <phone_ext>+33</phone_ext>
      <email>docteur@ovadia.fr</email>
    </contact>
    <investigator>
      <last_name>Hervé Ovadia, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Diaconesses Croix Saint-Simon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Marmor</last_name>
      <phone>144641600</phone>
      <phone_ext>+33</phone_ext>
      <email>smarmor@hopital-dcss.org</email>
    </contact>
    <investigator>
      <last_name>Simon Marmor, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre Bouget</last_name>
      <phone>549444492</phone>
      <phone_ext>+33</phone_ext>
      <email>pbouget@hotmail.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre Bouget, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de l'Atlantique</name>
      <address>
        <city>Puilboreau</city>
        <zip>17138</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cédric Bouquet</last_name>
      <phone>536288500</phone>
      <phone_ext>+33</phone_ext>
      <email>docteurbouquet@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Cédric Bouquet, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique de l'Orangerie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Dagrenat</last_name>
      <phone>388360088</phone>
      <phone_ext>+33</phone_ext>
      <email>dagrenat.ortho@gmail.com</email>
    </contact>
    <investigator>
      <last_name>David Dagrenat, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Polyclinique Sainte Thérèse</name>
      <address>
        <city>Sète</city>
        <zip>34200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Lozach</last_name>
      <phone>467536286</phone>
      <phone_ext>+33</phone_ext>
      <email>francois.lozach@gmail.com</email>
    </contact>
    <investigator>
      <last_name>François Lozach, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital privé du Vert Galant</name>
      <address>
        <city>Tremblay-en-France</city>
        <zip>93290</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Faouzi Madi</last_name>
      <phone>826309393</phone>
      <phone_ext>+33</phone_ext>
      <email>faouzimadi2@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Faouzi Madi, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre Ostéo-Articulaire des Cèdres</name>
      <address>
        <city>Échirolles</city>
        <zip>38130</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Claude Panisset</last_name>
      <phone>476481485</phone>
      <phone_ext>+33</phone_ext>
      <email>dr.panisset@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jean-Claude Panisset, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 6, 2021</study_first_submitted>
  <study_first_submitted_qc>September 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 6, 2021</last_update_submitted>
  <last_update_submitted_qc>September 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

